AVAC Comments to FDA on Vaccine and Related Biological Product Advisory Committee Meeting

Letters to Administration

AVAC comments provided to the Food and Drug Administration (FDA) in advance of the Vaccine and Related Biological Product Advisory Committee (VRBPAC) meeting on March 12, 2026.

Read the full letter.